載入...
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer
Concurrent chemoradiotherapy (CCRT) has become the standard of care for patients with unresectable stage III non–small cell lung cancer (NSCLC). The comparative merits of two widely used regimens: carboplatin/paclitaxel (PC) and cisplatin/etoposide (PE), each with concurrent radiotherapy, remain lar...
Na minha lista:
Main Authors: | , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Blackwell Publishing Ltd
2013
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3892396/ https://ncbi.nlm.nih.gov/pubmed/24403265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.142 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|